Celastrol has been found to be a potent anti-inflammatory and antitumor plant derivative recently. Herein we established an accurate reverse phase HPLC (RP-HPLC) determination method of celastrol, and prepared an effective nanoscale drug delivery system from the optimized formulations of celastrol-loaded carboxyl functioned poly(ethylene glycol)-block-poly(propylene glycol)-blockpoly(ethylene glycol)(PEO-block-PPO-block-PEO, Pluronic) polymeric nanomicelles. Rotatable central composite design (RCCD) and response surface methodology (RSM) were applied to improve the celastrol entrapment efficiency (EE), drug loading percentage (DLP), and decrease the particle size. The characteristics of the optimized micelles including particle size distribution, morphology, zeta potential and in vitro release of celastrol from micelles were carried out. Results showed that RP-HPLC method was successfully applied to detect and qualify the celastrol. The drug quantification range of the method was 20-200 g/mL with a linear correlation coefficient of greater than 0.999. The average accuracy (99.763%), the precision (0.521%) and recovery (99.63%) for this method were good. The optimal conditions for the preparation of celastrol-loaded polymeric nanomicelles were found to be: the celastrol/polymer weight ratio 8.5-9 mg/25 mg, hydration volume 11-17 mL. Under the optimal conditions, the EE was 100 3 ± 4 3%, DLP was 22 8 ± 1 0%, the average particle size was 117 3 ± 1 27 nm and the zeta potential was −2 19 ± 0 15 mV. Transmission electron micrograph (TEM) showed the micelles to be oval and rodlike shaped, with mean diameter around 20 nm. The in vitro experiments proved that celastrol in polymeric nanomicelles released gradually over the period of 24 h. These results showed that the RCCD and RSM could efficiently be applied for optimized preparation of celastrol-loaded polymeric nanomicelles.
INTRODUCTION
Celastrol (also known as tripterine, Fig. 1 ) is a pentacyclic-triterpene compound isolated from the Chinese herbal Thunder God Vine, which has been used as an antirheumatic in china with a long history. [1] [2] As one of the most promising medicinal molecules isolated from * Authors to whom correspondence should be addressed.
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the plant extracts of Chinese traditional medicines, celastrol has attracted more and more attention in recent years because it has been demonstrated to be a potent inhibitor of inflammation and cancer as well as alleviatie diseases of proteostasis deficiency. [3] [4] [5] [6] However, the clinical applications of celastrol have been hindered by its low solubility. Several methods have been developed to increase the water-solubility of poorly soluble drugs, [7] [8] [9] [10] [11] [12] but with limited successes. Recently, block copolymer micelles have attracted increased attention as a promising vehicle for poorly soluble drugs. [12] [13] [14] [15] [16] [17] [18] [19] One representative of such materials is poly(ethylene glycol)-block-poly(propylene glycol)-block-poly(ethylene glycol) (PEO-block-PPO-block-PEO)(Pluronic or Poloxamer) copolymers, which are amphiphilic synthetic polymers and non-toxic, biocompatible, bioabsorbable. [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] Generally, Pluronic block copolymers with concentration above CMC self-assemble into spherical polymeric micelles in water. Hydrophobic drugs may be physically incorporated within the core of the polymeric micelle by hydrophobic interactions. In this study, Pluronic P123 (PEO 20 -PPO 70 -PEO 20 , MW = 5750) was used to prepare an effective celastrol nano-micelles drug delivery system. However, in the preparation of celastrol nano-micelles drug delivery system, an important issue was to obtain an optimized pharmaceutical formulation. It is necessary to have a clear understanding of how preparation conditions determine micelle characteristics, drug entrapment efficiency (EE) and drug loading percentage (DLP), in particular, how these characteristics are influenced by potential interactions between preparation factors. These are of highest importance in clinical case of drugs like celastrol.
In order to readily achieve this goal, an accurate reverse phase HPLC (RP-HPLC) determination method of celastrol was firstly established, then rotatable central composite design (RCCD) and response surface methodology (RSM) were used to investigate and optimize the impact of critical factors namely celastrol/block copolymer (w/w) and hydration volume on the response properties such as EE, DLP and mean particle size. In addition, the characteristics of the optimized celastrol nano-micelles, including particle size distribution, morphology, zeta potentials, as well as in vitro drug release behavior were carried out. The optimized nano-micelles would be given as a potential clinical application of celastrol.
MATERIALS AND METHODS

Materials
Celastrol (99% purity) was purchased from Nanjing Zelang Pharmaceutical Technology Co., Ltd., China. Carboxyl-terminated poly(ethylene glycol)-blockpoly (propylene glycol)-block-poly(ethylene glycol) (PEOblock-PPO-block-PEO, Pluronic). P123 was received as gifts from Institute of Micro-Nano Science and Technology, Shanghai Jiao Tong University. Methanol (HPLC grade), alcohol and dichlormethane were obtained from Sinopharm Chemical Reagent Co., Ltd. (Shanghai, China).
RP-HPLC Method and Validity
Chromatographic Conditions
All RP-HPLC work was performed on an Agilent 1100 series HPLC system (Agilent Technologies, Santa Clara, U.S.A.), equipped with variable wavelength detector (VWD) and diode array detector (DAD). The output signal was monitored and processed using a Chemstation Software (Agilent). Chromatographic separations were achieved using a symmetry column (Agilent Eclipse plus C18) (250 nm ×4 6 nm, 5 m) at room temperature. The column was eluted with methonal-1% acetic acid solution (87:13 v/v) at a flow rate of 1.0 mL/min. The samples were detected at 425 nm. The injection volume was 50 L. The drug concentration was calculated from calibration curve.
Method Validation
The selectivity of the method was investigated by comparing the UV chromatograms of blank micelles, standard solution and celastrol loaded micelles; Calibration curve was determined by plotting the peak area (y) versus the nominal concentration (x) of celastrol in the concentration range of 20-200 g/mL; Accuracy of the assay method was determined for both intra-day and inter-day variations by analysing samples with low, medium and high celastrol concertrations; Recovery studies by spiking different concentrations of pure drug in a certain amount (25 mg) of carboxyl-terminated Pluronic P123 within the analytical concentration range of the proposed method. The mixture was extracted and analyzed following the procedure described under section 2.2.1. Three replicates were performed for the test.
Solubility Study
Excess celastrol was added to tampon-capped conical flask containing a fixed volume (50 mL) of buffer solution with different pH values ranging from 4 to 9. The mixture was stirred in swing bed at 25 C for 48 h with a speed of 150 rpm. Samples were centrifuged with a speed of 8000 rpm for 5 min. Celastrol concentration in the supernatants were measured by RP-HPLC as described above.
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Preparation of Micelles
Carboxyl-terminated Pluronic P123 nanomicelles filled with celasrtol was prepared using the thin-film hydration method as described previously. [31] [32] [33] Briefly, celastrol and carboxyl-terminated Pluronic P123 were dissolved into dichloromethane. After complete dissolution, the organic solvent was evaporated under reduced pressure at 25 C to form a thin, dry film layer on the wall of flask. The excess of organic solvents were removed by keeping the flask in dessicator for some time. Then the dried lipid film was hydrated with ultrapure water. Once hydrated, the nanomicelles dispersion was centrifuged with a speed of 8000 rpm for 5 min, and the non-encapsulated celastrol was removed from the solution. Then celastrol loaded carboxyl-terminated Pluronic P123 nanomicelles were obtained.
Rotatable Central Composite Design-Response Surface Methodology for Optimized Micelles
Preliminary experiments indicated that the variables, such as celastrol/polymer weight ratio, hydration volume, were the main factors that affected EE, DLP and mean particle size of celastrol-loaded micelles. However, it is very difficult to assess the impact of these factors individually or in combination, indicating the necessity of mathematical modeling in establishing the quantitative relationship between these factors. Here, the multi-objective optimization process was carried out through the rotatable central composite design (RCCD) and response surface methodology (RSM), which allows estimating the main and interaction effects of the investigated factors and predicting the best performance conditions with a minimum run of experiments. The details of the design are listed in Table I . For each factor, the experimental range was selected based on the preliminary experiments. In this study, carboxylterminated Pluronic P123 was set 25 mg. The value range of the variables was celastrol (X 1 of 5-15 mg, hydration volume (X 2 of 5-25 mL. A total of 13 tests were conducted. All formulations in these experiments were prepared in triplicate. The drug encapsulation efficiency (EE) and drug loading percentage (DLP) of celastrol-loaded micelles were calculated from formulas:
Where C e is the amount of drug incorporated in micelles. C c is the feeding amount of celastrol. C p is the amount of carboxyl-terminated Pluronic P123. 
Particle Size and Zeta Potential Analysis
Particle size and zeta potential of the prepared celastrol loaded micelles were analyzed by Dynamic light scattering (DLS) analyses using a NICOMP 380 ZLS Zeta Potential/Particle Sizer (PSS Nicomp, Santa Barbara, CA, USA) equipped with a 5 mW heliumneon laser at a wavelength of 633 nm and 90 scattering angle. 34 All samples were measured in triplicate and diluted with ultra-water to produce a suitable scattering intensity.
Transmission Electron Microscopy
The morphology of the micelles encapsulated with celastrol was observed using a JEOL JEM-2010 transmission electron microscope (TEM) at an acceleration voltage of 120 kV. One drop of the sample solution was placed on a 400 meshes copper grid precoated with a carbon film and the excess droplets were removed with filter paper. The samples were dried overnight and kept in the desiccator until examined with TEM.
In vitro Release Study
In vitro release study of the optimized celastrol loaded nanomicelles was performed in triplicate using dialysis membrane diffusion method. Briefly, 1 mL celastrol loaded micelles was introduced into a dialysis membrane bag (MWCO = 3500 Da, Spectrum Lab., Rancho Dominguez, CA) and sealed. The release experiment was initiated by placing the end-sealed dialysis bag in 50 mL PBS buffer (pH 7.4) containing 15% ethanol (v/v) at 37 C with a stirring speed of 100 rpm. Samples of 1 mL were withdrawn at predetermined time intervals and replaced with an equal volume of fresh medium. The concentration of celastrol in the samples was measured by RP-HPLC as described above. For comparison, pure drug suspension was conducted under the same conditions. Results are expressed as cumulative release of celastrol from micelles of three replicates.
Data Analysis
A mathematical polynomial equation model of design was established for analyzing the influence of the two factors. The polynomial equation obtained for each response property was analyzed using RSM. The optimum levels of the selected variables were obtained by solving the regression equation and also by analyzing the response surface contour and surface plots. In addition, statistical tests, such as analysis of variance (ANOVA), were performed to determine the statistical significance of each model with STA-TISTICA 6.0 software.
RESULTS AND DISCUSSION
Validation of Assay Method
Specificity
The representative chromatograms of blank micelles (A) and celastrol loaded micelles (B) are shown in Figure 2 . The peak of celastrol was symmetrical at a retention time of 14.5 min. No extraneous peaks were observed interfering with the separation and quantitation of celastrol. These observations indicated that the assay had adequate specificity. 
Linearity
The calibration curve of celastrol was linear in the range of 20-200 g/mL. The regression equation of the calibration curve was calculated as y = 42 849 × −105 549 (correlation coefficient, r > 0 999), where y is the peak area of celastrol and x is the concentration of celastrol. These results demonstrated a good linearity between the peak height ratios versus concentrations.
Precision and Accuracy
The summaries of intra-and inter-day precision/accuracy at low, medium and high concentrations of celastrol are listed in Table II . The intra-and inter-day precisions of celastrol are within 1%, and the intra-and inter-day accuracies are ranged from 98.32% to 100.68%, indicating good accuracy and precision of the method.
Recovery
Recovery reflects the extent of losses in the process of sample testing. The analytical method used in this study was accurate with recoveries of 98.6-100.8% (RSD < 1%).
Solubility of Celastrol
As to our knowledge, no paper has ever examined the effect of pH value on celastrol solubility. We found the pH value of solution has a major impact on the solubility of celastrol. As shown in Figure 3 , the solubility of celastrol in pH 4, 7.4 and 9 was respectively 1 g/mL, 11 g/mL and 200 g/mL. These data are very important to prepare an effective drug delivery system of celastrol. 
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Optimization Analysis
In the process of optimization analysis, a number of factors should be considered to get optimized results. The traditional optimization method of experimental design is timeconsuming, which may ignore the interactions between variables. 19 In recent years, RCCD-RSM, a combined analysis technique of mathematics and statistics, has been widely used to determine the effects of several variables and to optimize complicated chemical and biotechnological processes. 20 RCCD can offer possibility of analyzing larger number of variables at more levels with very few experimental runs. RSM optimization method can analyze interactions between variables. RCCD-RSM may define the interactions between factors, prevent doing unnecessarily numerous experiments and obtain the optimized results. In the present design, RCCD and RSM were successfully implemented for the optimization of preparation of celastrol loaded micelles.
Preparation of drug-loaded micelles is a complex procedure, unique attributes like EE, DLP and particle size are of most important features of drug-loaded micelles. High EE can improve utilization of celastrol, while high DLP may increase the biological functions of micelles. Micelles with appropriate particle size can prevent micelles from RES recognition and kidney clearance. Here we choose EE, DLP and particle size as the experiment investigation response. Table III showed the experimental results concerning the tested variables on EE, DLP and mean particle size. The three dependent values ranged from 48.7% to 99.8%, 16.6% to 28.4%, 91.5 nm to 200.3 nm respectively, which indicating the sensitivity toward the critical factors studied. The obtained data was fitted in quadratic model to describe the relationship between critical factors and response. The relationships are presented as follows: 
Where X 1 and X 2 represent the coded values of the celastrol and hydration volume respectively. The regression coefficient (R) of these equations were found to be 0.947, 0.956 and 0.953 respectively, which indicating good correlations between response and selected factors. The results were then analyzed by ANOVA with P < 0 01, indicating the quadratic model is highly statistically significant.
The obtained polynomial equations were further analyzed using RSM, and three-dimensional surface plots and overlapped contour plot were generated (Fig. 4) . Figure 4 (A), (B) and (C) showed the effect of celastrol and hydration volume on EE, DLP and particle size, respectively. Figure 4 (A) and (B) showed that an increase in the celastrol and hydration volume within limits leads to the increase in the EE and DLP, but the excessive celastrol and hydration volume lead to the decrease in the EE and DLP. Figure 4(C) showed that the increase of celastrol may increase the size of micelles while hydration volume had little effect on it. Figure 4(D) , (E) show the overlapped contour plot for EE and DLP, and for EE, DLP and particle size. The fitting results indicated that the optimized micelles with high EE, high DLP and small mean diameter was obtained at the celastrol/polymer ratio of 8.5-9 mg/25 mg by weight, hydration volume of 11-17 mL.
Formulation was verified by comparing predicted and observed value of EE, DLP and particle size. The bias of EE, DLP and particle size were 0.2%, 25.4% and 
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Micellar Size and Morphology
The diameter and particle size distribution of the celastrol loaded micelles were determined by DLS measurement. [36] [37] [38] The mean particle size of optimized micelles was 117 3±1 27 nm, and the polydispersity index was below 0.2, indicating that the micelles had a relatively narrow size distribution (Fig. 5) .
TEM shows that the micelles are oval and rod like (Fig. 6) . The size is about 20 nm, smaller than the data of DLS, which may be that the core segments of the micelles shrink easily with long hydrophobic chains of block copolymer and the hydrocarbon chains are more ordered in rod-shaped micelles compared to spherical micelles. 21 Another reason may be that the two methods are based on different sample preparation processes and different principles.
Zeta Potential Analysis of Optimal Micelles
The measurement of the zeta potential allows predictions about the storage stability of colloidal dispersion. In general, particle aggregation is less likely to occur for charged particles with high zeta potential due to electric repulsion. 22 In our study, zeta potential of micelles loaded with celastrol is −2 19 ± 0 15 mV, while that of empty micelles is −32 ± 0 78 mV. All nanoparticles are negatively charged, which could be attributed to the presence of ionized carboxyl groups on the surface of micelles. Drug solubilization seems to decrease the zeta potential of micelles. A tentative explanation is that the localization of hydrophobic drugs within the micelle corona may shield the surface charge by shifting the shear plane further from the micelle surface, leading to a reduced zeta potential. 23 38 Research showed that charged neutral micelles may keep long time circulation in the blood, because it can reduce the adsorption of micelles to negatively charged albumin and positively charged platelet surface, increase their stability in the blood. 24 39 
In vitro Release of Optimal Micelles
Maintaining a good sink condition for celastrol has been one of the difficulties in designing in vitro release experiments. [35] [36] [37] [38] [39] The solubility of celastrol in phosphate buffer (PBS, pH 7.4) is only 11 g/mL. Addition of a small amount of organic solvents, ethanol (15%, v/v), to the release media significantly increased the solubility of celastrol (40 g/mL). The maximum concentration of celastrol in the medium of this release experiment was 12 g/mL. These showed the system could provide a good sink condition for celastrol. Figure 7 shows the cumulative celastrol release profile from the optimized celastrol loaded micelles. Since the dialysis bag may become the rate-limiting step in the in vitro release of celastrol loaded micelles, in vitro release of celastrol from the stock solution across the dialysis membrane was carried out. Only 31.2% of celastrol was released from the micelles within 6 h, while 96.6% of celastrol in the stock solution was released during the same time period. The micelles released approximately 70% of celastrol during 24 h.
CONCLUSIONS
In the present study, thin-film hydration method was used to prepare the celastrol-loaded micelles. An accurate determination method for celastrol was established using RP-HPLC. RCCD-RSM was used to investigate and optimize the impact of critical factors on the response properties of mean particle size, drug loading percentage and entrapment efficiency. The optimized formulation provided a uniform small particle size with high entrapment efficiencies. Moreover, the optimized celastrol-loaded micelles were characterized by DLS, zeta potential analysis and TEM.
In vitro drug release study confirmed that 70% entrapped celastrol is released within 24 h in a controlled manner. Based on these findings, the proposed micelles formulation of celastrol may be given as an ideal clinical application delivery system and would be beneficial in better control of therapy with celastrol.
